InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: jbainseky post# 83816

Tuesday, 07/17/2012 6:48:17 PM

Tuesday, July 17, 2012 6:48:17 PM

Post# of 346112
Brings chills and excitement every time you read that part of the conference call! : )


Question regarding the partnering meetings. First of all, thanks for letting us know that you've had several, I think 15 you said. Are you willing to characterize whether or not these are with large pharmaceutical partners and if you prefer a U.S.-only deal or a worldwide deal or a non-U.S. deal? And then finally, are they with partners who are mostly oriented to chemotherapies, say, in lung cancer? Or partners who are actively pursuing or have pursued in the past immunotherapy in lung cancer?

Steven W. King

Sure, yes. I think that I would characterize most of the meetings we've had with -- have been with large pharmaceutical-type companies that are active in the oncology space. Of course, many if not all of these companies would have had chemotherapy-type agents in development. And ideally, we want a partner with some biologics experience. And so I think a, again, a majority of the potential partners have some sort of biologics experience in the space as well.

shorties are wondering what the heck to do at this point... do they want to wake up one morning to find we've jumped up 2-3-4 or 500% and be squeezed out ... or do they join the party!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News